LANTERN PHARMA INC (LTRN) Forecast, Price Target & Analyst Ratings

NASDAQ:LTRN • US51654W1018

Current stock price

2.49 USD
-0.05 (-1.97%)
At close:
2.53 USD
+0.04 (+1.61%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LANTERN PHARMA INC (LTRN).

Forecast Snapshot

Consensus Price Target

Price Target
$25.50
+ 924.10% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$25.50
Upside
+ 924.10%
From current price of $2.49 to mean target of $25.50, Based on 7 analyst forecasts
Low
$25.25
Median
$25.50
High
$26.25

Price Target Revisions

1 Month
25.00%
3 Months
25.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for LTRN. The average price target is 25.5 USD. This implies a price increase of 924.1% is expected in the next year compared to the current price of 2.49.
The average price target has been revised upward by 25% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LTRN Current Analyst RatingLTRN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

LTRN Historical Analyst RatingsLTRN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
LTRN was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about LTRN.
In the previous month the buy percentage consensus was at a similar level.
LTRN was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-04-02Lake StreetInitiate Buy
2024-04-25HC Wainwright & Co.Reiterate Neutral
2023-08-10EF HuttonReiterate Buy -> Buy
2023-06-26EF HuttonMaintains Buy -> Buy
2023-05-18HC Wainwright & Co.Initiate Neutral
2023-03-21EF HuttonReiterate Buy
2023-02-15EF HuttonMaintains Buy
2022-11-01EF HuttonInitiate Buy
2022-03-11HC Wainwright & Co.Maintains Buy
2021-11-02HC Wainwright & Co.Maintains Buy
2021-10-07HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
LTRN revenue by date.LTRN revenue by date.
N/AN/AN/AN/AN/AN/A
31.96%
EBITDA
YoY % growth
LTRN ebitda by date.LTRN ebitda by date.
N/A-2.43M-5.91M
-143.21%		-12.58M
-112.86%		-14.42M
-14.63%		-17.863M
-23.88%		-22.199M
-24.27%		N/A
-104.47%		N/A
-25.17%		N/A
-15.44%		N/A
-9.18%		N/A
0.71%		N/A
18.51%
EBIT
YoY % growth
LTRN ebit by date.LTRN ebit by date.
-1.73M-2.43M
-40.46%		-5.91M
-143.21%		-12.59M
-113.03%		-14.43M
-14.61%		-17.878M
-23.89%		-22.216M
-24.27%		N/A
12.65%		N/A
-15.63%		N/A
-5.68%		N/A
-5.38%		N/A
-5.10%		N/A
-8.74%
Operating Margin
LTRN operating margin by date.LTRN operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
LTRN eps by date.LTRN eps by date.
N/AN/AN/A-1.13
16.07%		-1.31
-15.93%		-1.48
-12.98%		-1.93
-30.41%		-1.57
18.65%		N/A
-24.09%		N/A
-5.76%		N/A
-4.46%		N/A
-4.27%		N/A
-8.18%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LTRN Yearly Revenue VS EstimatesLTRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 20M 40M 60M
LTRN Yearly EPS VS EstimatesLTRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-11.09%
EPS Next 5 Year
-9.11%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-41.56%
EBIT Next 5 Year
-25.19%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LANTERN PHARMA INC / LTRN Forecast FAQ

Can you provide the average price target for LANTERN PHARMA INC stock?

7 analysts have analysed LTRN and the average price target is 25.5 USD. This implies a price increase of 924.1% is expected in the next year compared to the current price of 2.49.

What is the next earnings date for LTRN stock?

LANTERN PHARMA INC (LTRN) will report earnings on 2026-05-05.

How do analysts rate LANTERN PHARMA INC (LTRN)?

The consensus rating for LANTERN PHARMA INC (LTRN) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.